glp 1 drugs risks Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning GLP-1 drugs linked to blood
Description
Phentermine, an oral drug, has been FDA-approved since 1959 but is less effective than GLP-1s
This review aims to summarize the evidence regarding the nephroprotective effects of glucagon-like peptide-1 receptor agonists (GLP-1RA) and tirzepatide and the putative mechanisms underlying the favorable renal profile of tirzepatide
[DOI] [PMC free article] [PubMed] [Google Scholar] 153.Pendergrass M, Fenton C, Haffner SM, Chen W
Oral rehydration solutions can help maintain balance during episodes
